Digital Health Is Changing Health Care. Is it Changing Pharma?

Digital health presents both opportunity and threat to Big Pharma. The opportunities lie in streamlining and accelerating R&D and improving patient experience and product outcomes; the threats come from the swath of new competitors vying for a piece of the health care value pie – many with far more experience in consumer-facing services.

When Google launched a health care company, Calico, in September 2013, few Big Pharma CEOs appeared to flinch. Google’s venture – its second foray into health care, after a first flop in 2011 – doesn’t present an immediate threat to pharma margins. But it symbolizes a bigger trend that is transforming the health care landscape, and pharma’s role within it: the rise of digital health.

The term is used broadly to encompass all technology-driven innovation applicable to health care, from consumer-facing mobile apps and monitors,...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from In Vivo Archive

More from In Vivo